- Home
- SGRP vs PYPD Comparison
SGRP vs PYPD Comparison
Compare SGRP & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGRP
- PYPD
- Stock Information
- Founded
- SGRP 1967
- PYPD 2008
- Country
- SGRP United States
- PYPD Israel
- Employees
- SGRP N/A
- PYPD N/A
- Industry
- SGRP Business Services
- PYPD Medical/Dental Instruments
- Sector
- SGRP Consumer Discretionary
- PYPD Health Care
- Exchange
- SGRP Nasdaq
- PYPD Nasdaq
- Market Cap
- SGRP 27.8M
- PYPD 26.7M
- IPO Year
- SGRP 1996
- PYPD 2020
- Fundamental
- Price
- SGRP $1.04
- PYPD $2.90
- Analyst Decision
- SGRP
- PYPD Strong Buy
- Analyst Count
- SGRP 0
- PYPD 2
- Target Price
- SGRP N/A
- PYPD $10.50
- AVG Volume (30 Days)
- SGRP 43.2K
- PYPD 19.1K
- Earning Date
- SGRP 05-27-2025
- PYPD 05-14-2025
- Dividend Yield
- SGRP N/A
- PYPD N/A
- EPS Growth
- SGRP N/A
- PYPD N/A
- EPS
- SGRP 0.50
- PYPD N/A
- Revenue
- SGRP $228,869,000.00
- PYPD N/A
- Revenue This Year
- SGRP N/A
- PYPD N/A
- Revenue Next Year
- SGRP N/A
- PYPD N/A
- P/E Ratio
- SGRP $2.14
- PYPD N/A
- Revenue Growth
- SGRP N/A
- PYPD N/A
- 52 Week Low
- SGRP $1.00
- PYPD $2.30
- 52 Week High
- SGRP $3.12
- PYPD $4.75
- Technical
- Relative Strength Index (RSI)
- SGRP 34.96
- PYPD 56.83
- Support Level
- SGRP $1.00
- PYPD $2.71
- Resistance Level
- SGRP $1.08
- PYPD $2.89
- Average True Range (ATR)
- SGRP 0.05
- PYPD 0.19
- MACD
- SGRP 0.01
- PYPD 0.02
- Stochastic Oscillator
- SGRP 26.67
- PYPD 56.25
About SGRP SPAR Group Inc.
SPAR Group Inc is a supplier of merchandising and other marketing services. It also provides range of services to retailers, consumer goods manufacturers and distributors around the globe. The company divides its operations into three reportable regional segments: Americas, which is comprised of United States, Canada, Brazil and Mexico; Asia-Pacific (APAC), which is comprised of Japan, China, and India; and Europe, Middle East and Africa (EMEA), which is comprised of South Africa. It generates maximum revenue from Americas.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.